Celldex Therapeutics (CLDX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Celldex Therapeutics (CLDX) over the last 15 years, with Q3 2025 value amounting to -$2.7 million.
- Celldex Therapeutics' Other Gross PP&E Adjustments rose 1429.02% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 1429.02%. This contributed to the annual value of $3.0 million for FY2024, which is 6768.51% down from last year.
- Celldex Therapeutics' Other Gross PP&E Adjustments amounted to -$2.7 million in Q3 2025, which was up 1429.02% from -$3.1 million recorded in Q2 2025.
- In the past 5 years, Celldex Therapeutics' Other Gross PP&E Adjustments ranged from a high of $11.4 million in Q4 2022 and a low of -$3.9 million during Q2 2022
- For the 5-year period, Celldex Therapeutics' Other Gross PP&E Adjustments averaged around -$803368.4, with its median value being -$2.9 million (2023).
- In the last 5 years, Celldex Therapeutics' Other Gross PP&E Adjustments surged by 6283.63% in 2022 and then tumbled by 6768.51% in 2024.
- Over the past 5 years, Celldex Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $7.0 million in 2021, then soared by 62.84% to $11.4 million in 2022, then dropped by 19.18% to $9.2 million in 2023, then crashed by 67.69% to $3.0 million in 2024, then tumbled by 191.42% to -$2.7 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$2.7 million for Q3 2025, versus -$3.1 million for Q2 2025 and -$3.5 million for Q1 2025.